Don't Eat the Marshmallow! 4 Tips for Financial Self-Control
Get the Lead Out: Lipsticks That Won't Hurt Your Pocketbook Or Your Health
$600 Million Powerball: 1 Winning Ticket Sold in Fla.
GM Shares Top Level Not Seen Since 2011
NASDAQ: ATHX
Athersys Presents New Data Demonstrating Potential Benefits From MultiStem After Spinal Cord Injury
Piper Jaffray's biotech/specialty pharma research team hold conference call
Publication Indicates That MultiStem Treatment May Reduce Inflammation and Promote Reparative Proce
Publication Indicates That MultiStem Treatment May Reduce Inflammation and Promote Reparative Processes Following Acute Brain Injury
Sabby reports 6.9% passive stake in Athersys
Athersys files to sell 17M shares of common stock
Athersys Wraps Up MultiStem Enrollment
Athersys price target raised to $6 from $3 at Maxim
Athersys (ATHX) Pops Higher on Strong MultiStem Data in Treating MS
Athersys Presents Research Progress in Its Multiple Sclerosis Program